Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on IGFBP-1 Production and Serum IGF-I in Subjects With Type 1 Diabetes Mellitus: An Open-label, Randomised, Triple Cross-over Trial.
Phase of Trial: Phase III
Latest Information Update: 03 Jan 2013
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary) ; Insulin suspension isophane (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Feb 2012 Planned number of patients changed from 16 to 24 and actual initiation date (Feb 2012) added as reported by European Clinical Trials Database.